Tech Mahindra to acquire US-based healthcare IT services firm CJS Solutions | business-news | Hindustan Times
Today in New Delhi, India
Mar 25, 2017-Saturday
New Delhi
  • Humidity
  • Wind

Tech Mahindra to acquire US-based healthcare IT services firm CJS Solutions

business Updated: Mar 06, 2017 20:37 IST
Tech Mahindra

An employee sits at the front desk inside Tech Mahindra office building in Noida on the outskirts of New Delhi.(Reuters file photo)

Information technology-giant Tech Mahindra on Monday announced that it has signed an agreement to acquire a US-based healthcare IT consulting company CJS Solutions Group LLC, which does business as The HCI Group.

Tech Mahindra will make an upfront payment of $89.5 million for purchase of 84.7% stake in the company. The balance stake of 15.3% will be acquired over a period of three years, it said in a statement.

The move is expected to strengthen position in healthcare provider space and give access to marquee customers and healthcare consultants, the statement added.

“Healthcare is one of the few sectors globally that is driving adoption of digital technologies. The acquisition will not only position Tech Mahindra as a significant player in the healthcare provider space, but will also provide an opportunity to go deeper in this space via EMR implementation and surrounding services route,” said CP Gurnani, MD & CEO of Tech Mahindra.

Headquartered in Jacksonville, The HCI Group works with global Tier-I healthcare service providers, primarily in the US and UK, focusing on providing end-to-end implementation of Electronic Health Record (EHR) and Electronic Medical Record (EMR) software, training and support services.

The HCI Group has a large pool of ‘Epic’ and ‘Cerner’ (healthcare software) certified professionals, and it is a leading implementation firm for these companies globally, it said.

For 12-month period ended September 20, 2016, HCI Group had revenues of $114 million. The Enterprise Value is $110 million.

The transaction is expected to close by April 2017, subject to the regulatory approvals.